HIPK2 and colorectal carcinoma: In addition, high levels of circulating exomiR-1229, associated with HIPK2 downregulation, could be also considered a potential prognostic biomarker in addition to being a potential therapeutic target for inhibiting tumor angiogenesis in CRC [45].